New treatment for relapsed or refractory Hodgkin's lymphoma

被引：4
|
作者：
Gourd, Elizabeth
机构：
来源：
LANCET ONCOLOGY | 2019年 / 20卷 / 06期
关键词：
D O I：
10.1016/S1470-2045(19)30289-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E298 / E298
页数：1
相关论文
共 50 条
  • [41] Efficiency of Nivolumab in Children with Refractory and Relapsed Hodgkin's and Non-Hodgkin's Lymphoma
    Kozlov, A.
    Iukhta, T.
    Gevorgian, A.
    Kazantzev, I.
    Tolkunova, P.
    Tsvetkova, L.
    Morozova, E.
    Lepik, K.
    Mikhailova, N.
    Zubarovskaya, L.
    Afanasyev, B.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S202 - S203
  • [42] Gemcitabine in the treatment of relapsed and refractory Hodgkin's disease
    Aurer, I
    Radman, I
    Nemet, D
    Zupancic-Salek, S
    Bogdanic, V
    Mrsic, M
    Sertic, D
    Labar, B
    ONKOLOGIE, 2005, 28 (11): : 567 - 571
  • [43] Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy
    Randall, Michael P.
    Spinner, Michael A.
    CANCERS, 2023, 15 (18)
  • [44] Treatment patterns for relapsed and refractory Hodgkin lymphoma in a community oncology setting
    Kumar, Anita J.
    Chao, Chun R.
    Rodday, Angie Mae
    Chang, Hong
    Xu, Lanfang
    Evens, Andrew M.
    Parsons, Susan K.
    LEUKEMIA & LYMPHOMA, 2022, 63 (05) : 1119 - 1126
  • [45] Transplant strategies in relapsed/refractory Hodgkin lymphoma
    Shah, Gunjan L.
    Moskowitz, Craig H.
    BLOOD, 2018, 131 (15) : 1689 - 1697
  • [46] Strategies for Management of Relapsed or Refractory Hodgkin Lymphoma
    Gordon, Leo I.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (5.5): : 716 - 718
  • [47] Treatment patterns and clinical outcomes among patients with relapsed/refractory classical Hodgkin's lymphoma
    Nisbett, Alnecia R.
    Yang, Xiaoqin
    Squires, Patrick
    Gautam, Santosh
    Desai, Kaushal
    Raut, Monika
    Nahar, Akash
    FUTURE ONCOLOGY, 2022, 18 (32) : 3623 - 3636
  • [48] Treatment of Relapsed Hodgkin Lymphoma
    Ansell, Stephen M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S88 - S90
  • [49] Where Do the New Drugs Fit in for Relapsed/Refractory Hodgkin Lymphoma?
    Khan, Niloufer
    Moskowitz, Alison J.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (03) : 227 - 233
  • [50] Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma
    Fosså, A
    Santoro, A
    Hiddemann, W
    Truemper, L
    Niederle, N
    Buksmaui, S
    Bonadonna, G
    Seeber, S
    Nowrousian, MR
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3786 - 3792
12345